Longitudinal assessment of oxaliplatin-induced neuropathy.
about
Chemotherapy-induced peripheral neurotoxicity: a critical analysisAAPT Diagnostic Criteria for Chronic Cancer Pain ConditionsThe Potential Role of Sensory Testing, Skin Biopsy, and Functional Brain Imaging as Biomarkers in Chronic Pain Clinical Trials: IMMPACT Considerations.Symptom management in the older adult: 2015 updateCorrespondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: secondary analysis of data from the CI-PeriNomS study.CXCR1/2 pathways in paclitaxel-induced neuropathic painComplex impairment of IA muscle proprioceptors following traumatic or neurotoxic injuryAmeliorative potential of Alstonia scholaris (Linn.) R. Br. against chronic constriction injury-induced neuropathic pain in rats.Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy.Persistent chemoneuropathy in patients receiving the plant alkaloids paclitaxel and vincristineCalendar time-specific propensity scores and comparative effectiveness research for stage III colon cancer chemotherapy.The effect of n-3 polyunsaturated fatty acids on incidence and severity of oxaliplatin induced peripheral neuropathy: a randomized controlled trialThe persistence of symptom burden: symptom experience and quality of life of cancer patients across one year.Pathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN).Treatment of oxaliplatin-induced peripheral neuropathy by intravenous mangafodipir.Uses of skin biopsy for sensory and autonomic nerve assessmentDorsal root ganglia hypertrophy as in vivo correlate of oxaliplatin-induced polyneuropathyA novel path to chronic proprioceptive disability with oxaliplatin: Distortion of sensory encoding.Clinical pattern and associations of oxaliplatin acute neurotoxicity: a prospective study in 170 patients with colorectal cancer.Peripheral neuropathy induced by microtubule-targeted chemotherapies: insights into acute injury and long-term recovery.Neoadjuvant treatment with cisplatin and S-1 in elderly patients with oesophagogastric adenocarcinoma and locoregional disease: Two case reports and review of the literature.Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial.Electroclinical biomarkers of early peripheral neurotoxicity from oxaliplatin.Oxaliplatin-induced Peripheral Neuropathy in South Indian Cancer Patients: A Prospective Study in Digestive Tract Cancer Patients.Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients.Microengineered peripheral nerve-on-a-chip for preclinical physiological testing.Probiotic DSF counteracts chemotherapy induced neuropathic pain.Characterization and diagnostic evaluation of chronic polyneuropathies induced by oxaliplatin and docetaxel comparing skin biopsy to quantitative sensory testing and nerve conduction studiesLong-term course of oxaliplatin-induced polyneuropathy: a prospective 2-year follow-up study
P2860
Q27010318-87516120-1CFF-48F1-885A-432D13DF5C12Q28079708-944342BB-80CA-40F6-9DBC-5F7572E5DC48Q30235485-9366591F-C698-4A43-9427-EE1272177780Q30374202-AD3EBC5D-59D2-4814-98BA-7F65F24A0305Q30818191-2F5681DF-07F6-421D-99A6-E978746EA6F5Q33618624-205BC72B-84F3-4DBC-BD40-AB5AB8156AF4Q35911716-FEBD725A-D7B5-4A74-9E5A-A509943CFB76Q36254520-D3BC7130-8FD4-4E7B-89EF-E1D922832122Q36439933-EEA0D3F2-91EE-4983-99A8-6C5AA98E6005Q36636831-3A3B373F-7764-4AAB-A073-B0D209349683Q36859634-B575FACD-DCFE-4F32-8480-AE91D423BC44Q37031281-29146C3C-753B-432C-A730-371F82A0DB52Q37056412-C205CF3D-B912-4648-BAFB-129D57D3767FQ37399781-4E75E273-12C4-46FA-8D8C-6B9839F64A05Q37410573-09201C11-A1EA-4E80-A2EC-FB2C086B0CCBQ38068367-9A6E4E31-01AE-40BA-93F9-48FA1E347EA8Q41512562-92CBD91C-4DE2-42B5-A5EE-EF5AD4B8243EQ42620905-9F1B999F-552B-4C71-889C-7613DB6427A5Q45091068-82053C33-D37B-4CB2-ACDC-ED345CA8666AQ46235962-1BA8BAB5-AC41-41DA-9C39-FF015F3DC971Q47146995-95ADAAD2-EE14-4CD8-B4EC-236F25FA7D6EQ47266458-D869F0F6-3090-406A-85B1-77FC494FC879Q49169362-9ABACD76-63F1-4DD8-A61F-35912949FD46Q49439093-37B2F200-FD49-42AF-A316-A70D2002137AQ50797877-E03D4813-9BC9-45DD-8AB1-320D69829B5FQ51495744-D44DF9A2-273A-4E20-B088-DCA3F0BB113AQ55370630-04F9FDA5-39BE-407F-A5CA-C580B5D5AD6AQ58455979-1F48C9DF-4761-4BA1-9EBA-09275B2640A8Q58874339-5EB9E568-0A4C-4880-AE61-BDA05E14F5ED
P2860
Longitudinal assessment of oxaliplatin-induced neuropathy.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Longitudinal assessment of oxaliplatin-induced neuropathy.
@ast
Longitudinal assessment of oxaliplatin-induced neuropathy.
@en
type
label
Longitudinal assessment of oxaliplatin-induced neuropathy.
@ast
Longitudinal assessment of oxaliplatin-induced neuropathy.
@en
prefLabel
Longitudinal assessment of oxaliplatin-induced neuropathy.
@ast
Longitudinal assessment of oxaliplatin-induced neuropathy.
@en
P2093
P2860
P50
P1433
P1476
Longitudinal assessment of oxaliplatin-induced neuropathy
@en
P2093
Michael Polydefkis
W Messersmith
P2860
P304
P356
10.1212/WNL.0B013E31822CFC59
P407
P577
2011-08-24T00:00:00Z